Year To Quarter End Statement Of Income

Mochida Pharmaceutical Co.,Ltd. - Filing #7616087

Concept 2021-04-01 to
2021-12-31
2020-04-01 to
2020-12-31
Year to quarter end statement of income
Statement of income
Net sales
84,814,000,000 JPY
79,881,000,000 JPY
Cost of sales
37,985,000,000 JPY
36,933,000,000 JPY
Gross profit (loss)
46,829,000,000 JPY
42,948,000,000 JPY
Selling, general and administrative expenses
33,783,000,000 JPY
31,755,000,000 JPY
Selling, general and administrative expenses
Operating profit (loss)
13,045,000,000 JPY
11,184,000,000 JPY
Non-operating income
Interest income
1,000,000 JPY
2,000,000 JPY
Dividend income
284,000,000 JPY
245,000,000 JPY
Non-operating income
440,000,000 JPY
351,000,000 JPY
Non-operating expenses
Non-operating expenses
39,000,000 JPY
108,000,000 JPY
Ordinary profit (loss)
13,447,000,000 JPY
11,428,000,000 JPY
Extraordinary income
Gain on sale of non-current assets
JPY
5,000,000 JPY
Extraordinary income
526,000,000 JPY
32,000,000 JPY
Extraordinary losses
Loss on disaster
2,000,000 JPY
JPY
Extraordinary losses
215,000,000 JPY
197,000,000 JPY
Profit (loss) before income taxes
13,757,000,000 JPY
11,263,000,000 JPY
Income taxes
3,577,000,000 JPY
2,855,000,000 JPY
Profit (loss)
10,180,000,000 JPY
8,407,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.